Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Licensed alternatives including semaglutide (Wegovy), tirzepatide (Mounjaro), and orlistat are currently available in the UK for eligible patients
Retatrutide metabolic benefits Retatrutide produces all of the metabolic benefits seen with Mounjaro plus additional improvements that appear unique to triple agonism: Blood sugar control: HbA1c reductions of 1.3% to 2.0% at doses of 4-12 mg in type 2 diabetes Blood pressure: Systolic blood pressure reduction of up to 14.0 mmHg at the highest dose (roughly double what Mounjaro achieves) Lipids: Non-HDL cholesterol and triglyceride reductions Prediabetes reversal: 72% of participants with prediabetes at baseline reverted to normoglycemia Inflammatory markers: Significant reductions in high-sensitivity C-reactive protein But the standout metabolic benefit, the one that has researchers most excited, is the effect on liver health
Are they right for me
This hormone affects appetite, the stomach, and the digestive system
Semaglutide offers proven safety, pharmaceutical access, cardiovascular data, and good tolerability with meaningful weight loss
Starting during a relatively calm period rather than alongside major life changes sets you up for success
